$KITE to Present at the 2015 Jefferies Immuno-Oncology Summit in Boston

0
1053

Kite Pharma to Present at the 2015 Jefferies Immuno-Oncology Summit in Boston

SANTA MONICA, Calif., April 10, 2015 (GLOBE NEWSWIRE) — Kite Pharma, Inc., (KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT(TM)) products for the treatment of cancer, today announced that Arie Belldegrun, M.D., FACS, Chairman, President and Chief Executive Officer, will present a company overview at the 2015 Jefferies Immuno-Oncology Summit in Boston. The presentation will take place on Wednesday, April 15, 2015, at 8:10 a.m. EDT.

About Kite Pharma

Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on eACT(TM) designed to restore the immune system’s ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com.

Contact:
Kite Pharma
Cynthia M. Butitta
Chief Financial Officer and Chief Operating Officer
310-824-9999
For Media: Justin Jackson
For Investor Inquiries: Lisa Burns and Nancy Yu
Burns McClellan
212-213-0006
jjackson@burnsmc.com
lburns@burnsmc.com
nyu@burnsmc.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here